Survey of referrals to electroconvulsive therapy in Hungary

Gazdag, Gábor; Sebestyén, Gábor; Zsargó, Eszter; Tolna, Judit; Ungvári, Gábor S.

doi:10.1080/15622970802256180

Cited by 7 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hence the question arises whether they are open to ECT as a valid treatment option and whether they have enough knowledge to advise their patients adequately. In other countries, the lack of experience of psychiatrists dealing with ECT also has been bemoaned (Yuzda et al 2002;Gazdag et al 2009b;Dinwiddie and Spitz 2010). Specialist training and continuing education for referring physicians appears to us to be a central point for a better patient access to ECT treatment.…”

Section: Remarkable Single Resultsmentioning

confidence: 99%

Accessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: A German example

Loh

Nickl‐Jockschat

Sheldrick

et al. 2012

The World Journal of Biological Psychiatry

View full text Add to dashboard Cite

show abstract

Section: Remarkable Single Resultsmentioning

confidence: 99%

Accessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: A German example

Loh

Nickl‐Jockschat

Sheldrick

et al. 2012

The World Journal of Biological Psychiatry

View full text Add to dashboard Cite

show abstract

“…The criteria for ECT prescription are not consistent in the current literature; however, different treatment guidelines propose its indication in patients with schizophrenia with catatonia symptoms, as additional support for pharmacotherapy when there is resistance to treatment, and in patients with a prior positive response to ECT [136,141,142]. It has been reported that treatment resistance is the most common condition in which ECT is prescribed [143]. Furthermore, the symptomatic and cognitive response has been higher when bifrontal electrodes are used [144].…”

Section: Schizophreniamentioning

confidence: 99%

Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications

Rojas

Ariza

Ortega

et al. 2022

IJMS

View full text Add to dashboard Cite

Electroconvulsive therapy (ECT) is based on conducting an electrical current through the brain to stimulate it and trigger generalized convulsion activity with therapeutic ends. Due to the efficient use of ECT during the last years, interest in the molecular bases involved in its mechanism of action has increased. Therefore, different hypotheses have emerged. In this context, the goal of this review is to describe the neurobiological, endocrine, and immune mechanisms involved in ECT and to detail its clinical efficacy in different psychiatric pathologies. This is a narrative review in which an extensive literature search was performed on the Scopus, Embase, PubMed, ISI Web of Science, and Google Scholar databases from inception to February 2022. The terms “electroconvulsive therapy”, “neurobiological effects of electroconvulsive therapy”, “molecular mechanisms in electroconvulsive therapy”, and “psychiatric disorders” were among the keywords used in the search. The mechanisms of action of ECT include neurobiological function modifications and endocrine and immune changes that take place after ECT. Among these, the decrease in neural network hyperconnectivity, neuroinflammation reduction, neurogenesis promotion, modulation of different monoaminergic systems, and hypothalamus–hypophysis–adrenal and hypothalamus–hypophysis–thyroid axes normalization have been described. The majority of these elements are physiopathological components and therapeutic targets in different mental illnesses. Likewise, the use of ECT has recently expanded, with evidence of its use for other pathologies, such as Parkinson’s disease psychosis, malignant neuroleptic syndrome, post-traumatic stress disorder, and obsessive–compulsive disorder. In conclusion, there is sufficient evidence to support the efficacy of ECT in the treatment of different psychiatric disorders, potentially through immune, endocrine, and neurobiological systems.

show abstract

“…A survey of referrals to ECT in Hungary reports that treatment resistance is the most common indication, followed by catatonic symptoms, and a past history of good response to ECT. [ 10 ] A recent Cochrane review reports that ECT can be considered for patients when rapid improvement is desired and when there is a history of poor response to medication alone. [ 11 ]…”

Section: Introductionmentioning

confidence: 99%

“…A survey of the practice of ECT in teaching hospitals in India, as well as in Asia, reports that schizophrenia (36.5% and 41.8% subsequently) is the most common diagnosis for which patients receive ECT. [ 10 11 ] Therefore, the lingering questions remain as to why schizophrenia patients receive ECT in our country? We have made an attempt to study this in an academic Psychiatric setting in India.…”

Section: Introductionmentioning

confidence: 99%

Why do we prescribe ECT to schizophrenia patients?

Phutane

Thirthalli

Muralidharan

et al. 2011

Indian J Psychiatry

View full text Add to dashboard Cite

Electroconvulsive therapy (ECT) is prescribed for schizophrenia patients for various indications, in our country. However, official guidelines in other countries have been cautious in prescribing ECT for schizophrenia. To study the indications for which patients with schizophrenia receive ECT. We studied records of schizophrenia inpatients receiving ECT in one year (2005) (n=101) retrospectively, as well as the consecutive data of patients between May 2007 and June 2008 (n=101) prospectively. The various indications for ECT in schizophrenia were studied by frequency analysis. Of the 202 schizophrenia patients who received ECT, the most common reason was ‘to augment pharmacotherapy’ in (n=116) cases. The target symptoms for which ECT was prescribed the most was catatonia (n=72). The mean number of ECTs (SD) received was 8.4 (2.8). Augmentation of pharmacotherapy was the most common indication of ECT in patients with schizophrenia.

show abstract

Survey of referrals to electroconvulsive therapy in Hungary

Cited by 7 publications

References 17 publications

Accessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: A German example

Accessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: A German example

Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications

Why do we prescribe ECT to schizophrenia patients?

Contact Info

Product

Resources

About